Dáil Éireann Debate, Tuesday - 9 November 2021
647. Deputy Pádraig O'Sullivan asked the Minister for Health further to Parliamentary Questions Nos. 1150 and 1151 of 31 March 2021, when his Department will act on the recommendation of a company (details supplied); the timeline for same; and if he will make a statement on the matter. [54552/21]
View answerFollowing a tender by the Office of Government Procurement, Mazars conducted a review of the governance structures around the HSE's drug reimbursement process. The report was submitted to my Department in January 2020.
The review made recommendations in respect of the HSE’s systems, structures, processes, governance arrangements and use of specialist resources in respect of the drug reimbursement process.
The report was under consideration by officials, however the focus of the Department of Health changed to the immediate public health considerations of the COVID-19 pandemic and the preservation of life. This meant that this work stream was suspended to reallocate resources to support essential services.
My Department aims to complete its consideration of the report’s recommendations in the near future.
